UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Molecular Genetics and Prospects for Therapy of the Inherited Retinal Dystrophies
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Article
  • Publication date:
    2001
  • Pagination:
    307, 316
  • Journal:
    Current Opinion in Genetics and Development
  • Volume:
    11
  • Issue:
    3
  • Editors:
    Bessant DA,Ali A,Battacharya SS
  • Print ISSN:
    0959-437X
  • Keywords:
    anatomy & histology, As, BLINDNESS, cell, Cell Transplantation, critical, drug therapy, extracellular, Extracellular Matrix, EXTRACELLULAR-MATRIX, Eye, Eye Proteins, FACTOR GENE, factors, Form, FORMS, GENE, Gene Therapy, GENE-THERAPY, Genes, genetic, Genetic Diseases, Inborn, genetics, IM, LA, MATRIX, Matrix Protein, metabolism, Molecular, novel, NUMBER, Patient, patients, Pharmacological, Photoreceptors, Phototransduction, PROGRESS, PROTEIN, Proteins, recycling, retina, Retinal Degeneration, Review, strategies, strategy, therapeutic, THERAPIES, therapy, TRANSCRIPTION, TRANSCRIPTION FACTOR, Transcription Factors, transplantation, transporter, treatment, Treatments, vitamin, Vitamin A, genetic, MI
Abstract
More than 60 genes responsible for human retinal dystrophies have been identified. Those recently isolated include the transcription factor genes NRL and NR2E3, RDH5 (retinol dehydrogenase), EFEMP1 (which encodes an extracellular matrix protein), CRB1, PROML1, RP1, AIPL1 and USH1C (harmonin). The ABCR protein has been identified as a critical transporter in the recycling of retinal (vitamin A). At present, a number of novel therapeutic strategies are being evaluated including pharmacological treatments, cell transplantation and gene therapy. The progress made with such approaches now offers hope to patients with these incurable forms of blindness
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Author
Institute of Ophthalmology
Author
Institute of Ophthalmology
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by